English

ALGOS PHARMACEUTICAL CORP

EDGAR

Quarterly report (10-Q) · filed 2000-05-15

17 filing records in this dataset, filed from 1996-11-14 to 2000-05-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2000-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-2.54 million USD

2000-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -2541000 USD Source

Free cash flow

-2.59 million USD

2000-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -2541000 USD Source
Capital Expenditure: 50000 USD Source

Cash and cash equivalents: 28.2 million USD 2000-03-31 Source
Exact value

28247000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Revenue: 0 USD · 1999-04-01 – 1999-06-30 Source
Revenue: 0 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 0 USD · 1999-01-01 – 1999-12-31 Source
Revenue: 0 USD · 1999-01-01 – 1999-09-30 Source
Revenue: 0 USD · 2000-01-01 – 2000-03-31 Source

Net income

-15.2 million USD

1999-04-01 – 2000-03-31

Exact inputs and evidence

Net income: -5019312 USD · 1999-04-01 – 1999-06-30 Source
Net income: -3321545 USD · 1999-07-01 – 1999-09-30 Source
Net income: -17743000 USD · 1999-01-01 – 1999-12-31 Source
Net income: -13751436 USD · 1999-01-01 – 1999-09-30 Source
Net income: -2876000 USD · 2000-01-01 – 2000-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-05-15.

Financial data available through: 1999-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1999-12-31
Operating income: 6 of 11 periods available· newest 1999-12-31
Net income: 6 of 11 periods available· newest 1999-12-31
Operating cash flow: 6 of 11 periods available· newest 1999-12-31
Capital expenditure: 6 of 11 periods available· newest 1999-12-31
Total assets: 5 of 11 periods available· newest 1999-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 1999-12-31
Current liabilities: 5 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

1998-01-01 – 1998-12-31
Current period

USD 0

1999-01-01 – 1999-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
0 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1403 Input fundies:Revenue: 0 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1403
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 1.87 million

Prior period

−USD 15.87 million

1998-01-01 – 1998-12-31
Current period

−USD 17.74 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-17743000 − -15870000 = -1873000 USD

-15870000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-17743000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Year-over-year change in Net income: -1873000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -17743000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1451 Input fundies:NetIncome: -15870000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1451
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 163,000

Prior period

−USD 15.33 million

1998-01-01 – 1998-12-31
Current period

−USD 15.49 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-15488000 − -15325000 = -163000 USD

-15325000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-15488000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Year-over-year change in Operating cash flow: -163000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -15488000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 Input fundies:OperatingCashFlow: -15325000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-79.3%

Prior period

USD 1.1 million

1998-01-01 – 1998-12-31
Current period

USD 227,000

1999-01-01 – 1999-12-31

Exact inputs and evidence

227000 − 1095000 = -868000 USD

1095000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
227000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Year-over-year change in Capital expenditure: -868000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 227000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 Input fundies:CapitalExpenditure: 1095000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 0
Operating costs Derived USD 19.79 million
Operating income −USD 19.79 million
Tax, interest and other Derived −USD 2.05 million
Net income −USD 17.74 million

Cash

Operating cash flow −USD 15.49 million
Capital expenditure USD 227,000
Free cash flow Derived −USD 15.72 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Operating loss: operating costs were 291% of revenue.
1997 Operating loss: operating costs were 1,226% of revenue.
1998 Not shown: operating income or net income is not reported.
1999 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	0	1276933 Derived	-1276933	-153247 Derived	-1123686	-1098685 Derived	Source 1994-01-01 – 1994-12-31: 0 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -1276933 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -1123686 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -991928 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 106757 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	0	2374983 Derived	-2374983	-252548 Derived	-2122435	-1951821 Derived	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -2374983 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -2122435 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -1929321 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 22500 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	2000000	5810193 Derived	-3810193	-722715 Derived	-3087478	-1586620 Derived	Source 1996-01-01 – 1996-12-31: 2000000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -3810193 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -3087478 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -1556604 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 30016 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	1000000	12258000 Derived	-11258000	-2435000 Derived	-8823000	-7408000 Derived	Source 1997-01-01 – 1997-12-31: 1000000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -11258000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -8823000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -7297000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 111000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	0	17899000 Derived	-17899000	-2029000 Derived	-15870000	-16420000 Derived	Source 1998-01-01 – 1998-12-31: 0 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -17899000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -15870000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -15325000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1095000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	0	19794000 Derived	-19794000	-2051000 Derived	-17743000	-15715000 Derived	Source 1999-01-01 – 1999-12-31: 0 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -19794000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -17743000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -15488000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 227000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	0	Revenue: 0 Open source
19951995-12-31	Revenue	0	Revenue: 0 Open source
19961996-12-31	Revenue	2000000	Revenue: 2000000 Open source
19971997-12-31	Revenue	1000000	Revenue: 1000000 Open source
19981998-12-31	Revenue	0	Revenue: 0 Open source
19991999-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19951995-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 2000000 Open source Revenue: 0 Open source
19971997-12-31	Year over year	-50%	Revenue: 1000000 Open source Revenue: 2000000 Open source
19981998-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 1000000 Open source
19991999-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,125.8% 1997

Net margin -882.3% 1997

Free cash flow margin -740.8% 1997

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	Not reported	Operating Income: -1276933 Open source Revenue: 0 Open source
19951995-12-31	Operating margin	Not reported	Operating Income: -2374983 Open source Revenue: 0 Open source
19961996-12-31	Operating margin	-190.5%	Operating Income: -3810193 Open source Revenue: 2000000 Open source
19971997-12-31	Operating margin	-1,125.8%	Operating Income: -11258000 Open source Revenue: 1000000 Open source
19981998-12-31	Operating margin	Not reported	Operating Income: -17899000 Open source Revenue: 0 Open source
19991999-12-31	Operating margin	Not reported	Operating Income: -19794000 Open source Revenue: 0 Open source
19941994-12-31	Net margin	Not reported	Net Income: -1123686 Open source Revenue: 0 Open source
19951995-12-31	Net margin	Not reported	Net Income: -2122435 Open source Revenue: 0 Open source
19961996-12-31	Net margin	-154.4%	Net Income: -3087478 Open source Revenue: 2000000 Open source
19971997-12-31	Net margin	-882.3%	Net Income: -8823000 Open source Revenue: 1000000 Open source
19981998-12-31	Net margin	Not reported	Net Income: -15870000 Open source Revenue: 0 Open source
19991999-12-31	Net margin	Not reported	Net Income: -17743000 Open source Revenue: 0 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -991928 Open source Capital Expenditure: 106757 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1929321 Open source Capital Expenditure: 22500 Open source
19961996-12-31	Free cash flow margin	-79.3%	Revenue: 2000000 Open source Operating Cash Flow: -1556604 Open source Capital Expenditure: 30016 Open source
19971997-12-31	Free cash flow margin	-740.8%	Revenue: 1000000 Open source Operating Cash Flow: -7297000 Open source Capital Expenditure: 111000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -15325000 Open source Capital Expenditure: 1095000 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -15488000 Open source Capital Expenditure: 227000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -15.5M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-991928	Operating Cash Flow: -991928 Open source
19951995-12-31	Operating cash flow	-1929321	Operating Cash Flow: -1929321 Open source
19961996-12-31	Operating cash flow	-1556604	Operating Cash Flow: -1556604 Open source
19971997-12-31	Operating cash flow	-7297000	Operating Cash Flow: -7297000 Open source
19981998-12-31	Operating cash flow	-15325000	Operating Cash Flow: -15325000 Open source
19991999-12-31	Operating cash flow	-15488000	Operating Cash Flow: -15488000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -15.7M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-1098685	Operating Cash Flow: -991928 Open source Capital Expenditure: 106757 Open source
19951995-12-31	Free cash flow	-1951821	Operating Cash Flow: -1929321 Open source Capital Expenditure: 22500 Open source
19961996-12-31	Free cash flow	-1586620	Operating Cash Flow: -1556604 Open source Capital Expenditure: 30016 Open source
19971997-12-31	Free cash flow	-7408000	Operating Cash Flow: -7297000 Open source Capital Expenditure: 111000 Open source
19981998-12-31	Free cash flow	-16420000	Operating Cash Flow: -15325000 Open source Capital Expenditure: 1095000 Open source
19991999-12-31	Free cash flow	-15715000	Operating Cash Flow: -15488000 Open source Capital Expenditure: 227000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
1995-12-31	Liabilities / assets	Not reported	Total Assets: 3820452 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 49201741 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 42360478 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 52430000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 36309000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.91× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	12.41×	Current Assets: 3718157 Open source Current Liabilities: 299632 Open source
19961996-12-31	Current assets / current liabilities	50.24×	Current Assets: 48905802 Open source Current Liabilities: 973470 Open source
19971997-12-31	Current assets / current liabilities	14.98×	Current Assets: 38968979 Open source Current Liabilities: 2601391 Open source
19981998-12-31	Current assets / current liabilities	16.18×	Current Assets: 47128000 Open source Current Liabilities: 2912000 Open source
19991999-12-31	Current assets / current liabilities	8.91×	Current Assets: 35204000 Open source Current Liabilities: 3951000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 1.12 million Exact value Exact value: -1123686 USD 1994-01-01 – 1994-12-31: -1123686 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALGOS PHARMACEUTICAL CORP · 1994-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Net Income: -1123686 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1123686 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-97-000518.txt#1365 The citation records this snapshot. The page link may show a newer release later.	−USD 991,928 Exact value Exact value: -991928 USD 1994-01-01 – 1994-12-31: -991928 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALGOS PHARMACEUTICAL CORP · 1994-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Operating Cash Flow: -991928 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -991928 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-97-000518.txt#1381 The citation records this snapshot. The page link may show a newer release later.	USD 106,757 Exact value Exact value: 106757 USD 1994-01-01 – 1994-12-31: 106757 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALGOS PHARMACEUTICAL CORP · 1994-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Capital Expenditure: 106757 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 106757 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-97-000518.txt#1385 The citation records this snapshot. The page link may show a newer release later.	−USD 1.1 million Calculation and evidence -991928 − 106757 USD Exact free cash flow: -1098685 USD 1994-01-01 – 1994-12-31: -991928 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 106757 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALGOS PHARMACEUTICAL CORP · 1994-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Free cash flow: -1098685 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -991928 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-97-000518.txt#1381 Input fundies:CapitalExpenditure: 106757 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-97-000518.txt#1385 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 2.12 million Exact value Exact value: -2122435 USD 1995-01-01 – 1995-12-31: -2122435 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALGOS PHARMACEUTICAL CORP · 1995-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Net Income: -2122435 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2122435 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-98-000686.txt#1374 The citation records this snapshot. The page link may show a newer release later.	−USD 1.93 million Exact value Exact value: -1929321 USD 1995-01-01 – 1995-12-31: -1929321 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALGOS PHARMACEUTICAL CORP · 1995-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Operating Cash Flow: -1929321 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1929321 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-98-000686.txt#1392 The citation records this snapshot. The page link may show a newer release later.	USD 22,500 Exact value Exact value: 22500 USD 1995-01-01 – 1995-12-31: 22500 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALGOS PHARMACEUTICAL CORP · 1995-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Capital Expenditure: 22500 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22500 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-98-000686.txt#1396 The citation records this snapshot. The page link may show a newer release later.	−USD 1.95 million Calculation and evidence -1929321 − 22500 USD Exact free cash flow: -1951821 USD 1995-01-01 – 1995-12-31: -1929321 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 22500 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALGOS PHARMACEUTICAL CORP · 1995-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Free cash flow: -1951821 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1929321 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-98-000686.txt#1392 Input fundies:CapitalExpenditure: 22500 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-98-000686.txt#1396 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 3.09 million Exact value Exact value: -3087478 USD 1996-01-01 – 1996-12-31: -3087478 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALGOS PHARMACEUTICAL CORP · 1996-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Net Income: -3087478 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3087478 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-99-000933.txt#1438 The citation records this snapshot. The page link may show a newer release later.	−USD 1.56 million Exact value Exact value: -1556604 USD 1996-01-01 – 1996-12-31: -1556604 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALGOS PHARMACEUTICAL CORP · 1996-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Operating Cash Flow: -1556604 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1556604 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-99-000933.txt#1458 The citation records this snapshot. The page link may show a newer release later.	USD 30,016 Exact value Exact value: 30016 USD 1996-01-01 – 1996-12-31: 30016 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALGOS PHARMACEUTICAL CORP · 1996-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Capital Expenditure: 30016 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30016 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-99-000933.txt#1463 The citation records this snapshot. The page link may show a newer release later.	−USD 1.59 million Calculation and evidence -1556604 − 30016 USD Exact free cash flow: -1586620 USD 1996-01-01 – 1996-12-31: -1556604 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 30016 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALGOS PHARMACEUTICAL CORP · 1996-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Free cash flow: -1586620 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1556604 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-99-000933.txt#1458 Input fundies:CapitalExpenditure: 30016 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-99-000933.txt#1463 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 8.82 million Exact value Exact value: -8823000 USD 1997-01-01 – 1997-12-31: -8823000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALGOS PHARMACEUTICAL CORP · 1997-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Net Income: -8823000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8823000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1451 The citation records this snapshot. The page link may show a newer release later.	−USD 7.3 million Exact value Exact value: -7297000 USD 1997-01-01 – 1997-12-31: -7297000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALGOS PHARMACEUTICAL CORP · 1997-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Operating Cash Flow: -7297000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7297000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 The citation records this snapshot. The page link may show a newer release later.	USD 111,000 Exact value Exact value: 111000 USD 1997-01-01 – 1997-12-31: 111000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALGOS PHARMACEUTICAL CORP · 1997-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Capital Expenditure: 111000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 111000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 The citation records this snapshot. The page link may show a newer release later.	−USD 7.41 million Calculation and evidence -7297000 − 111000 USD Exact free cash flow: -7408000 USD 1997-01-01 – 1997-12-31: -7297000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 111000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALGOS PHARMACEUTICAL CORP · 1997-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Free cash flow: -7408000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7297000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 Input fundies:CapitalExpenditure: 111000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 15.87 million Exact value Exact value: -15870000 USD 1998-01-01 – 1998-12-31: -15870000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALGOS PHARMACEUTICAL CORP · 1998-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Net Income: -15870000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15870000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1451 The citation records this snapshot. The page link may show a newer release later.	−USD 15.33 million Exact value Exact value: -15325000 USD 1998-01-01 – 1998-12-31: -15325000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALGOS PHARMACEUTICAL CORP · 1998-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Operating Cash Flow: -15325000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15325000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 The citation records this snapshot. The page link may show a newer release later.	USD 1.1 million Exact value Exact value: 1095000 USD 1998-01-01 – 1998-12-31: 1095000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALGOS PHARMACEUTICAL CORP · 1998-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Capital Expenditure: 1095000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1095000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 The citation records this snapshot. The page link may show a newer release later.	−USD 16.42 million Calculation and evidence -15325000 − 1095000 USD Exact free cash flow: -16420000 USD 1998-01-01 – 1998-12-31: -15325000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1095000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALGOS PHARMACEUTICAL CORP · 1998-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Free cash flow: -16420000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15325000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 Input fundies:CapitalExpenditure: 1095000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 17.74 million Exact value Exact value: -17743000 USD 1999-01-01 – 1999-12-31: -17743000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Net Income: -17743000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17743000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1451 The citation records this snapshot. The page link may show a newer release later.	−USD 15.49 million Exact value Exact value: -15488000 USD 1999-01-01 – 1999-12-31: -15488000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Operating Cash Flow: -15488000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15488000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 The citation records this snapshot. The page link may show a newer release later.	USD 227,000 Exact value Exact value: 227000 USD 1999-01-01 – 1999-12-31: 227000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Capital Expenditure: 227000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 227000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 The citation records this snapshot. The page link may show a newer release later.	−USD 15.72 million Calculation and evidence -15488000 − 227000 USD Exact free cash flow: -15715000 USD 1999-01-01 – 1999-12-31: -15488000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 227000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALGOS PHARMACEUTICAL CORP · 1999-12-31 ALGOS PHARMACEUTICAL CORP (edgar:924862) Free cash flow: -15715000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-04T10:33:50Z Snapshot: cc306d336184eb61fe670b01a6e05588c59e0965322c8b51f1ac16e4ed6a5666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/924862?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15488000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1469 Input fundies:CapitalExpenditure: 227000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/924862/0000950117-00-000794.txt#1474 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

17 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0000924862, 924862, edgar:924862

ALGOS PHARMACEUTICAL CORP

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation